Last updated on August 2019

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma


Brief description of study

This clinical trial is a randomized Phase 2 evaluation of CB-839 (telaglenastat) in combination with cabozantinib versus placebo with cabozantinib in patients with advanced or metastatic Renal Cell Carcinoma with a clear cell component.

Detailed Study Description

This clinical trial is a randomized Phase 2 evaluation of CB-839 (telaglenastat) in combination with cabozantinib versus placebo with cabozantinib in Renal Cell Carcinoma patients with at least one and not more than 2 prior therapies in the advanced or metastatic setting.

Clinical Study Identifier: NCT03428217

Find a site near you

Start Over

University of Chicago

Chicago, IL United States
  Connect »

Roswell Park Cancer Center

Buffalo, NY United States
  Connect »

University of Maryland

Baltimore, MD United States
  Connect »

UPMC Hillman Cancer Center

Pittsburgh, PA United States
  Connect »

Northern Westchester Hospital

Mount Kisco, NY United States
  Connect »

Karmanos Cancer Institute

Detroit, MI United States
  Connect »

NYU Winthrop Hospital

Mineola, NY United States
  Connect »

Allegheny General Hospital

Pittsburgh, PA United States
  Connect »

Stony Brook Cancer Center

Stony Brook, NY United States
  Connect »

University of Michigan

Ann Arbor, MI United States
  Connect »

MD Anderson

Houston, TX United States
  Connect »

Cairns Hospital

Cairns, Australia
  Connect »

Penrose Research Department

Colorado Springs, CO United States
  Connect »

Fox Chase Cancer Center

Philadelphia, PA United States
  Connect »

West Cancer Center

Germantown, TN United States
  Connect »

Levine Cancer Institute

Charlotte, NC United States
  Connect »

MidAmerica Division Inc.

Kansas City, MO United States
  Connect »

Tweed Hospital

Tweed Heads, Australia
  Connect »

Stanford Cancer Center

Palo Alto, CA United States
  Connect »

Mercy Hospital

Joplin, MO United States
  Connect »

Christchurch Hospital

Christchurch, New Zealand
  Connect »

Mayo Clinic Cancer Center

Phoenix, AZ United States
  Connect »

St. Joseph Heritage Healthcare

Santa Rosa, CA United States
  Connect »

Florida Cancer Specialists

Fort Myers, FL United States
  Connect »

Florida Cancer Specialists

Saint Petersburg, FL United States
  Connect »

Northwestern University

Chicago, IL United States
  Connect »

HCA Midwest Health

Kansas City, MO United States
  Connect »

Cabrini Hospital

Malvern, Australia
  Connect »

Centre Jean Perrin

Clermont Ferrand, France
  Connect »

Ochsner Clinic Foundation

New Orleans, LA United States
  Connect »